Status: current, Defined. Date: 31-Jan 2023. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4768631000168117 | Vyxeos (cytarabine 100 mg + daunorubicin hydrochloride 44 mg) powder for injection, vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
4768641000168114 | Vyxeos powder for injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Vyxeos powder for injection, 1 vial | has TPUU | True | Vyxeos powder for injection, vial | Inferred relationship | Some | 1658728123 |
Vyxeos powder for injection, 2 vials | has TPUU | True | Vyxeos powder for injection, vial | Inferred relationship | Some | 288691836 |
Vyxeos powder for injection, 1 vial | has TPUU | True | Vyxeos powder for injection, vial | Inferred relationship | Some | 1153616887 |
Vyxeos powder for injection, 2 vials | has TPUU | True | Vyxeos powder for injection, vial | Inferred relationship | Some | 202035133 |
Reference Sets
Black Triangle Scheme reference set
Trade product unit of use reference set